The integration of GenAI and LLMs within pharmacy has the potential to accelerate development processes and pave the way for a new and practical approach to customized therapies. These developments may contribute to the future integration of personalized formulation strategies in pharmaceutical development, contingent upon robust validation and regulatory alignment.
Shinde et al. (Fri,) studied this question.